|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0010583,
umls-concept:C0012634,
umls-concept:C0023981,
umls-concept:C0024143,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0205263,
umls-concept:C0209368,
umls-concept:C0348016,
umls-concept:C0441655,
umls-concept:C2607943,
umls-concept:C2926606
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-1-13
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
To assess the effect of mycophenolate mofetil compared with intravenous pulses of cyclophosphamide on the nonrenal manifestations of lupus nephritis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
211-21
|
|
pubmed:dateRevised |
2010-10-13
|
|
pubmed:meshHeading |
pubmed-meshheading:20039429-Adult,
pubmed-meshheading:20039429-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:20039429-Antibodies, Antinuclear,
pubmed-meshheading:20039429-Complement System Proteins,
pubmed-meshheading:20039429-Cyclophosphamide,
pubmed-meshheading:20039429-Drug Therapy, Combination,
pubmed-meshheading:20039429-Female,
pubmed-meshheading:20039429-Glucocorticoids,
pubmed-meshheading:20039429-Humans,
pubmed-meshheading:20039429-Immunosuppressive Agents,
pubmed-meshheading:20039429-Injections, Intravenous,
pubmed-meshheading:20039429-Lupus Nephritis,
pubmed-meshheading:20039429-Male,
pubmed-meshheading:20039429-Mycophenolic Acid,
pubmed-meshheading:20039429-Prednisone,
pubmed-meshheading:20039429-Prospective Studies,
pubmed-meshheading:20039429-Remission Induction,
pubmed-meshheading:20039429-Severity of Illness Index,
pubmed-meshheading:20039429-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
|
|
pubmed:affiliation |
State University of New York Downstate Medical Center, Brooklyn, NY, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
